[1]
S. M. Allaqaband and F. Naqashbandi, “Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection”, J. Drug Delivery Ther., vol. 12, no. 1, pp. 149–150, Jan. 2022, doi: 10.22270/jddt.v12i1.5309.